Insider: Treace John T. Chief Executive Officer - TREACE MEDICAL CONCEPTS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 6,796,190 | 0 | 6,796,190 |
| Value | $44,684,949.25 | $0.00 | $44,684,949.25 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 03/04/2025 | AAP | 60,000 | Direct | COM | $8.73 | $524,064.00 | 6,796,190 |
| 09/16/2024 | AAP | 50,000 | Direct | COM | $5.31 | $265,630.00 | 6,523,095 |
| 08/14/2024 | AAP | 85,000 | Direct | COM | $6.00 | $510,314.50 | 6,473,095 |
| 06/11/2024 | AAP | 45,000 | Direct | COM | $5.88 | $264,600.00 | 6,388,095 |
| 05/17/2024 | AAP | 100,000 | Direct | COM | $5.56 | $556,170.00 | 6,343,095 |
| 05/14/2024 | AAP | 150,000 | Direct | COM | $5.12 | $767,805.00 | 6,243,095 |
| 05/13/2024 | AAP | 150,000 | Direct | COM | $4.56 | $683,490.00 | 6,093,095 |
| 05/10/2024 | AAP | 150,000 | Direct | COM | $4.58 | $686,880.00 | 5,943,095 |
| 03/09/2023 | DDS | 2,075 | Direct | COM | $24.41 | $50,650.75 | 5,539,380 |
| 11/21/2022 | AAP | 15,000 | Direct | COM | $21.83 | $327,405.00 | 5,541,455 |
| 11/17/2022 | AAP | 10,000 | Direct | COM | $21.67 | $216,714.00 | 5,526,455 |
| 09/01/2022 | AAP | 10,000 | Direct | COM | $19.80 | $198,031.00 | 5,516,455 |
| 08/26/2022 | AAP | 21,491 | Direct | COM | $20.95 | $450,341.76 | 5,506,455 |
| 08/24/2022 | AAP | 509 | Direct | COM | $18.92 | $9,631.91 | 5,484,964 |
| 08/23/2022 | AAP | 28,000 | Direct | COM | $18.72 | $524,123.60 | 5,484,455 |
| 12/29/2021 | DDS | 3,075 | Direct | COM | $17.01 | $52,314.98 | 5,422,580 |
| 12/28/2021 | DDS | 19,760 | Direct | COM | $16.99 | $335,803.42 | 5,425,655 |
| 12/27/2021 | DDS | 17,165 | Direct | COM | $17.44 | $299,373.05 | 5,445,415 |
| 12/23/2021 | DDS | 22,795 | Direct | COM | $16.96 | $386,541.65 | 5,462,580 |
| 12/22/2021 | DDS | 41,710 | Direct | COM | $16.29 | $679,355.80 | 5,485,375 |
| 12/21/2021 | DDS | 34,047 | Direct | COM | $16.09 | $547,649.40 | 5,530,622 |
| 12/21/2021 | DDS | 3,537 | Direct | COM | $16.37 | $57,893.97 | 5,527,085 |
| 12/20/2021 | DDS | 22,311 | Direct | COM | $15.74 | $351,112.67 | 5,565,269 |
| 12/20/2021 | DDS | 600 | Direct | COM | $16.31 | $9,784.02 | 5,564,669 |
| 11/24/2021 | DDS | 25,743 | Direct | COM | $17.66 | $454,703.76 | 5,617,837 |
| 1 2 Next Last You are at page 1 of 2 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research